Paul Tudor Jones: “Crypto is clearly winning”

Shares of Novavax are down sharply after Politico reported the company is having problems manufacturing its highly anticipated Covid-19 vaccine. Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, discusses Covid therapeutics, vaccines, and the U.S. production and manufacturing system. Paul Tudor Jones, founder and CIO at Tudor Investment Corporation and founder of the Robin Hood Foundation, shares his inflation trades and portfolio breakdown. The legendary hedge fund manager also explains which assets investors should stay away from as the Federal Reserve slowly reacts to rising prices. New York City has announced an expansion of its Covid vaccine mandate to all public employees, removing the option to test out. Plus, Facebook may soon be rebranded with a new name. In this episode: Dr. Scott Gottlieb, @ScottGottliebMD Paul Tudor Jones, @ptj_official Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin